Plasma C3d levels as a diagnostic marker for complete complement factor I deficiency - 04/02/21
Doi : 10.1016/j.jaci.2020.08.014
Leslie Naesens, MD a, b, Julie Smet, MD c, Simon J. Tavernier, MD, PhD a, d, Petra Schelstraete, MD, PhD e, Levi Hoste, MD a, e, Stijn Lambrecht, PhD f, Helene Verhelst, MD, PhD g, Jutte van der Werff ten Bosch, MD, PhD h, Alina Ferster, MD, PhD i, Sophie Blumental, MD i, Pascale Hilbert, PhD j, Tessa Kerre, MD, PhD b, Johan Vande Walle, MD, PhD k, Christoph Licht, MD l, Lubka T. Roumenina, PhD m, Patrick Stordeur, PhD c, ∗, Filomeen Haerynck, MD, PhD a, e, ∗ 
a Primary Immunodeficiency Research Lab, Center for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Center, Ghent University Hospital, Ghent, Belgium
b Department of Hematology, Center for Primary Immunodeficiency Ghent, Jeffrey Modell Diagnosis and Research Center, Ghent University Hospital, Ghent, Belgium
c Belgian National Reference Center for the Complement System, Laboratory of Immunology, LHUB-ULB, Université Libre de Bruxelles, Brussels, Belgium
d Laboratory of Immunoregulation, VIB Inflammation Research Center, Ghent, Belgium
e Department of Pediatrics, Division of Pediatric Pulmonology, Infectious Diseases and Immunology, Ghent University Hospital, Ghent, Belgium
f Division of Laboratory Medicine, Department of Clinical Chemistry, Ghent University Hospital, Ghent, Belgium
g Department of Pediatrics, Division of Pediatric Neurology, University Hospital Ghent, Ghent, Belgium
h Department of Pediatrics, Division of Pediatric Oncology and Immunology, Universitair Ziekenhuis Brussel, Jette, Belgium
i Department of Pediatrics, Department of Haematology-Oncology, Children's University Hospital Queen Fabiola, Université Libre de Bruxelles, Brussels, Belgium
j Department of Human Genetics, Institut de Pathologie et Génétique, Gosselies, Belgium
k Department of Pediatrics, Division of Pediatric Nephrology, University Hospital Ghent, Ghent, Belgium
l Department of Pediatrics, Division of Pediatric Nephrology, The Hospital for Sick Children, Toronto, Ontario, Canada
m Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France
| Supported by the Ghent University Hospital Spearhead Initiative for Immunology Research and the Jeffrey Modell Foundation (to F.H). |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2020
American Academy of Allergy, Asthma & Immunology. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 147 - N° 2
P. 749 - Febbraio 2021 Ritorno al numero
Articolo precedente
- Lupus-like autoimmunity and increased interferon response in patients with STAT3-deficient hyper-IgE syndrome
- Rishi R. Goel, Shuichiro Nakabo, Brian L.P. Dizon, Amanda Urban, Meryl Waldman, Lillian Howard, Dirk Darnell, Munir Buhaya, Carmelo Carmona-Rivera, Sarfaraz Hasni, Mariana J. Kaplan, Alexandra F. Freeman, Sarthak Gupta
- Drug allergy to CFTR modulator therapy associated with lumacaftor-specific CD4+ T lymphocytes
- Jobst F. Roehmel, Monday O. Ogese, Alexander Rohrbach, Marcus A. Mall, Dean J. Naisbitt
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?